No Association between Polymorphisms in theHistone DeacetylaseGenes and the Risk of Lung Cancer
Open Access
- 1 July 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 14 (7) , 1841-1843
- https://doi.org/10.1158/1055-9965.epi-05-0200
Abstract
Histone deacetylases (HDAC) mediate changes in chromatin structure by removing acetyl groups from the core histones, and they play an important role in the regulation of gene expression (1). HDACs are involved in cell cycle progression, differentiation, and apoptosis, and their deregulation is associated with several cancers (1, 2). Several candidate polymorphisms in the HDAC genes have been deposited in public databases (http://www.ncbi.nlm.nih.gov/SNP). Although the functional effects of these polymorphisms have not been elucidated, we have hypothesized that some of these variants and particularly their haplotypes may have an effect on HDAC activities and thus modulate the susceptibility to lung cancer. To test this hypothesis, a case-control study was conducted to evaluate the association between the HDAC genotypes/haplotypes and the risk of lung cancer.Keywords
This publication has 6 references indexed in Scilit:
- XPC polymorphisms and lung cancer riskInternational Journal of Cancer, 2005
- Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung CancerCancer Epidemiology, Biomarkers & Prevention, 2005
- DNMT3B polymorphisms and risk of primary lung cancerCarcinogenesis: Integrative Cancer Research, 2004
- Histone deacetylases and cancer: causes and therapiesNature Reviews Cancer, 2001
- Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatinHuman Molecular Genetics, 2001
- A New Statistical Method for Haplotype Reconstruction from Population DataAmerican Journal of Human Genetics, 2001